bioLIVE China
Since bioLIVE China, the global biomedical technology exhibition in Shanghai, was first held in 2012, it has grown into one of Asia’s largest trade fairs focusing on products and technologies in the sciences. of life, biotechnology and innovative medicines. This year, the special exhibition space will be opened again in Shanghai and will be combined with high-end conferences and join hands with the “China Global Pharmaceutical Ingredients Exhibition” (CPhI China) to provide a platform for industry-wide to professionals in the biopharmaceutical sector. , biotechnology, research and development of new drugs and pharmaceutical investment. A leading international expansion platform for product presentation, knowledge sharing, technology exchange and service transformation.
bioLIVE China, the global biomedical technology exhibition in Shanghai, China, will simultaneously host more than 30 pharmaceutical research and development conferences, focusing on cutting-edge industry insights, attended by more than 70,000 professional pharmaceutical buyers. the entire pharmaceutical industry chain; come to the site; more than 3,000 leading companies will exhibit at the same time and participate in the Pharmaceutical Industry Extravaganza.
The latest exhibition in Shanghai, China (bioLIVE China), had a total exhibition area of 40,000 square meters, with 600 exhibitors from Hong Kong, South Korea, Japan, Germany, Italy, Spain, Brazil, the United States, Russia and Dubai. , India, etc. The number of visitors to the exhibition reached 52,000.
Exhibition Address: Shanghai New International Exhibition Center
Sponsoring organization:Informative markets
Standard stand price:
Please log in to view booth prices
Gross space stand price:
Please log in to view booth prices
Holding period:Once a year
Exhibition space:40,000 square meters
Number of exhibitors:600
Number of visitors:52,000 visitors
Things to note:Exhibition time and location are subject to change, so please confirm before attending.
Biological products and emerging therapies: recombinant proteins, peptides, nucleic acids, vaccines, blood products, therapeutic antibodies, cell and gene therapy, tumor immunotherapy, stem cells & iPS
Biotechnology and R&D platform services: molecular biology, cellular biology, proteomics and metabolomics, biotechnology platform services, bioinformatics services, R&D and drug production services, clinical research services
Bioprocesses, manufacturing and solutions: cell culture media, biological reagents, consumables for biological experiments, bioreactors, biochemical separation media, protein purification systems, process development